Caboxen Cabozantinib 20 mg Capsules

Caboxen Cabozantinib 20 mg Capsules are a breakthrough medication meticulously engineered to combat specific types of advanced cancers. Each capsules contains 20 mg of cabozantinib, a potent inhibitor targeting key pathways involved in tumor growth and angiogenesis.

Mode of Action: Cabozantinib, the active ingredient in Caboxen Cabozantinib 20 mg capsules, inhibits multiple receptor tyrosine kinases involved in tumor cell proliferation, angiogenesis, and metastasis. By blocking these signaling pathways, cabozantinib helps suppress tumor growth and spread.

Indications: Caboxen Cabozantinib 20 mg capsules are indicated for the treatment of:

• Advanced Renal Cell Carcinoma (Kidney Cancer)
• Hepatocellular Carcinoma (Liver Cancer)
• Medullary Thyroid Cancer

Dosage and Administration: The recommended dosage of Caboxen Cabozantinib 20 mg is one capsules (20 mg) to be taken orally once daily. Dosage adjustments may be necessary based on individual patient factors and tolerance. capsules can be taken with or without food, but consistency in administration is crucial.

Precautions:

• Prior to initiating treatment with Caboxen Cabozantinib 20 mg capsules, patients should undergo thorough medical evaluation, including assessment of cardiac function and blood pressure.
• Close monitoring of blood pressure, liver function, and thyroid function is essential during therapy.
• Patients should avoid consuming grapefruit or grapefruit juice while taking Caboxen Cabozantinib 20 mg capsules, as it may increase drug levels in the bloodstream.

Side Effects: Common side effects associated with Caboxen Cabozantinib 20 mg capsules may include:

• Fatigue
• Diarrhea
• Nausea
• Decreased appetite
• High blood pressure
• Palmar-plantar erythrodysesthesia (hand-foot syndrome)
• Weight loss
• Changes in taste